Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
The appointment follows NewcelX's recently announced successful FDA Type B Pre-IND meeting for NCEL-101, providing a clear regulatory pathway toward clinical trials Dr. Ricordi to support advancement...
-
San Antonio, Texas, July 07, 2026 (GLOBE NEWSWIRE) -- BBG Advanced Therapies, a subsidiary of nonprofit BioBridge Global (BBG), today announced a collaboration with Kite, a Gilead Company and global...
-
HOUSTON, July 07, 2026 (GLOBE NEWSWIRE) -- CoRegen, Inc., a biopharmaceutical company pursuing novel treatments for patients living with some of the most aggressive forms of cancer, today announced...
-
Spur Therapeutics Announces First Patient Dosed in GALILEO-3 Pivotal Clinical Trial of FLT201 for the Treatment of Gaucher Disease Type 1
-
PETACH TIKVA, Israel, July 07, 2026 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT | TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services,...
-
Marie Washburn appointed CFO at Longeveron.
-
CANTON, Mass., July 06, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on product solutions for the Advanced Wound Care and...
-
Austin, United States, July 03, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Fluorescent In Situ Hybridization Probe Market was valued at USD 1,034.61 Million in 2025 and is expected to...
-
Global Integrated Passive Devices Market Size, Share, Revenue Trends & Segmentation Analysis Report by Application, End Use, Region and Forecast 2026–2035
-
Silver Spring, MD, July 01, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today approved Tregzi, the first regulatory T (Treg) cell-based immunotherapy for improving chronic...